IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 228 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,427,103 | -88.3% | 1,412,550 | -81.9% | 0.02% | -88.3% |
| Q2 2023 | $54,820,374 | +2.0% | 7,786,985 | -11.5% | 0.16% | -2.4% |
| Q1 2023 | $53,768,360 | +267.6% | 8,800,059 | +1880.5% | 0.17% | +122.7% |
| Q3 2020 | $14,628,000 | -69.1% | 444,342 | -74.2% | 0.08% | -75.7% |
| Q2 2020 | $47,283,000 | -53.9% | 1,722,515 | -49.7% | 0.31% | -62.9% |
| Q1 2020 | $102,535,000 | +32.0% | 3,425,226 | +22.1% | 0.83% | +104.2% |
| Q4 2019 | $77,649,000 | +444.8% | 2,805,230 | +258.2% | 0.41% | +363.6% |
| Q3 2019 | $14,254,000 | +31.0% | 783,203 | +76.5% | 0.09% | +54.4% |
| Q2 2019 | $10,880,000 | – | 443,710 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 565,890 | $26,257,000 | 9.39% |
| Consonance Capital Management LP | 1,710,803 | $79,381,000 | 7.41% |
| GREAT POINT PARTNERS LLC | 917,427 | $42,569,000 | 6.91% |
| Avoro Capital Advisors LLC | 7,500,000 | $348,000,000 | 5.99% |
| Ghost Tree Capital, LLC | 500,000 | $23,200,000 | 5.17% |
| FRAZIER MANAGEMENT LLC | 1,312,999 | $60,923,000 | 4.69% |
| Perceptive Advisors | 9,166,304 | $425,316,000 | 4.56% |
| Ally Bridge Group (NY) LLC | 360,000 | $16,704,000 | 2.86% |
| Orbimed Advisors | 6,645,100 | $308,333,000 | 2.70% |
| ACUTA CAPITAL PARTNERS, LLC | 164,800 | $7,647,000 | 2.08% |